Clinical Trials Directory

Trials / Completed

CompletedNCT02583698

Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices

Efficacy of Nonselective Beta Blockers vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Acute on chronic liver failure patients with HVPG (Hepatic Venous Pressure Gradient) ≥ 12 mmHg + No/small esophageal varices who present to the Department of Hepatology at Institute of Liver and Billiary Sciences, who meet the inclusion criteria and who provide informed consent.

Conditions

Interventions

TypeNameDescription
DRUGCarvedilol
DRUGPlacebo

Timeline

Start date
2015-10-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2015-10-22
Last updated
2019-06-04

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02583698. Inclusion in this directory is not an endorsement.

Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophage (NCT02583698) · Clinical Trials Directory